Equaline Tioconazole 1 Ointment
Product Images NDC 41163-032

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Equaline Tioconazole 1 (NDC 41163-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United Natural Foods, Inc. Dba Unfi, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tioconazole 1 Image (426 El Tioconazole 1 Image)

Packaging label for Equaline Tioconazole-1 vaginal ointment 6.5%, a 1-dose treatment containing tioconazole. The label states it includes 1 pre-filled applicator with 0.16 oz (4.6 g) ointment and is distributed by Supervalu Inc. The label highlights comparisons to Monistat and provides usage and warning information.*

FDA Label Image

Image 1 (Image 01)

An anatomical illustration showing female genitalia with labels identifying the vulva, urinary opening, opening of the vagina, and anus. The diagram uses arrows to point to each anatomical feature for clarity.*

FDA Label Image

Figure 1 (Image 02)

An instructional diagram labeled Fig. 1 showing components of a vaginal applicator for Equaline Tioconazole 1 ointment. It identifies the plunger (tip and base), applicator tube with a purple cap base, and illustrates assembling or preparing the applicator by pushing the plunger into the tube.*

FDA Label Image

Figure 2 (Image 03)

Illustration showing the parts of a vaginal applicator for Equaline Tioconazole 1 ointment, including the plunger, applicator tube, and a removable purple cap indicated by a rotating arrow.*

FDA Label Image

Figure 3 (Image 04)

Illustration figure 3 showing a side view anatomical diagram highlighting the vaginal area and urethra, likely for instructional use related to vaginal ointment application.*

FDA Label Image

Figure 4 (Image 05)

An instructional anatomical line drawing labeled as Figure 4, showing the side view of a female pelvis and vaginal area, with an arrow indicating the proper application site of the medication inside the vagina.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.